Placebo for ABBV-903

DRUG2 trials

Sponsors

AbbVie

Conditions

Healthy VolunteerHealthy Volunteers

Phase 1

A Study to Assess Adverse Events and How Single and Multiple Ascending Doses of ABBV-903 Move Through the Body in Healthy Adults

CompletedNCT05691699

AbbVieHealthy Volunteer

Start: 2023-01-03End: 2023-10-23Updated: 2023-10-30

A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese Participants

TerminatedNCT06009237

AbbVieHealthy Volunteers

Start: 2023-08-23End: 2023-10-30Updated: 2023-11-13

Related Papers

Pharmacokinetic profiling of limnetrelvir in non-Japanese and Japanese populations: results of two phase 1 single- and multiple-dose studies.

2026-03-23